Loading...

Sun Pharmaceutical Industries Limited

SUNPHARMA.NS•NSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹1847.90
₹13.50(0.74%)
Indian Market opens in 25h 30m

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) Stock Overview

Explore Sun Pharmaceutical Industries Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.4T
P/E Ratio40.62
EPS (TTM)$45.49
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$1835.29
3 Months$1570.12
1 Year Target$2105.78

SUNPHARMA.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2105.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.62 and a market capitalization of 4.4T. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.74%
5-Day Change
1.53%
1-Month Change
7.77%
3-Month Change
9.01%
6-Month Change
9.25%
Year-to-Date (YTD) Change
7.45%
1-Year Change
4.57%
3-Year Change
92.12%
5-Year Change
164.67%
All-Time (Max) Change
102561.11%

Contact Information

https://www.sunpharma.com
91 22 4324 4324
Sun House, Mumbai, NaN, 400063

Company Facts

430,000 Employees
IPO DateJan 1, 1996
CountryIN
Actively Trading

Frequently Asked Questions